Susceptibilities of oral bacteria and yeast to mammalian cathelicidins - Wikidata - awgldk - TriplyDB

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins

http://www.wikidata.org/entity/Q39478909

about

Antimicrobial peptides in the oral environment: expression and function in health and disease.Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals.Implications of the innate immune response to adenovirus and adenoviral vectors.Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.Innate immune response to adenovirus.Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent Innate immune response to oral bacteria and the immune evasive characteristics of periodontal pathogens.Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria.Diminished Antimicrobial Peptide and Antifungal Antibiotic Activities against Candida albicans in Denture Adhesive Promise of Combining Antifungal Agents in Denture Adhesives to Fight Candida Species Infections.Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms.Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock.Risk factors associated with denture stomatitis in the United States.SMAP29 congeners demonstrate activity against oral bacteria and reduced toxicity against oral keratinocytes.Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils.Gingival crevicular fluid levels of human beta-defensin-2 and cathelicidin in smoker and non-smoker patients: a cross-sectional study.Expression and regulation of novel human beta-defensins in gingival keratinocytes.Salivary levels of antibacterial peptide (LL-37/hCAP-18) and cotinine in patients with chronic periodontitis.Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue.

P2860

Q34684398-EA93B585-B07B-4C8B-BBB6-58CD3C326020 Q34943566-FFC2B203-AC32-4C5E-BC01-0A386F3D9A9C Q35085363-AB151585-7EBE-4CFF-817E-5FC60160F4B4 Q35203439-233586E2-85E2-4BDD-98EB-8A1E64E5A0E4 Q35920633-0BCD9490-75E3-4662-A3BB-BC5892915E7A Q36278163-4612371C-8B33-4489-9868-E9BF7840EF56 Q36425009-BF09DF95-0077-44D3-99DB-EAF92820A1EC Q36681720-E0A08C30-B3B7-4B32-82B9-DD7FDA988E90 Q36932099-C7063B6F-9818-4F92-B94D-4A33454DDA13 Q40340089-12D1DDC0-91A0-4DF9-8EFD-3E7637032901 Q40442488-6AB383DC-34B0-4D46-A3E6-6FEB6B3AEE4E Q40638341-B776437F-1DA9-48C6-8C25-078F794EAC13 Q43506522-9009EB99-F339-4280-9AE6-8820387DA7B6 Q46536629-23F4AF7D-3293-4D05-B15C-FE4CE62215A0 Q46750707-2B7F7432-5DBF-4903-BD86-AED49EDE1371 Q50680057-40245689-BC47-4539-B697-EF5B73C5033A Q50950571-4004735F-C79B-4A2E-8AFD-74D36E1980BD Q51052601-BECFB60E-88EA-4EEB-9AFF-63157BE28407 Q54347097-999A4E9C-E96A-4CB6-AA66-B8486BA46EBB Q54576734-166B1E0C-27A5-482A-BC18-3FD4F2629169

P2860

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins

http://www.wikidata.org/entity/Q39478909

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins

@en

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins.

@nl

type

label

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins

@en

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins.

@nl

prefLabel

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins

@en

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins.

@nl

P1433

Q39478909-6349FA08-0571-42F1-BB00-A3B1C8852DAE

P1476

Q39478909-0DF5A8EE-2BBF-4333-A873-B524C0CA4437

P2093

Q39478909-1F9EFCC5-6BE4-4E2A-A529-2E25974E8CF8

Q39478909-5383ADE5-4087-4500-A06D-F76A4D1C3A13

Q39478909-5D26A952-2406-4504-8D3A-B1C229FD3155

Q39478909-8AA8199A-CB27-4EEE-8881-4473308F7B16

Q39478909-C7AC2643-4956-4FCF-80CA-E1C82DCE3DDA

Q39478909-C911D8A0-63E2-43E5-8526-433917B956A3

Q39478909-D0783421-0DA7-4C3F-B332-A412ACBCFD94

P2860

Q39478909-0305E97D-4D0C-4DF3-860A-53C17F93FB17

Q39478909-141703A7-AA68-417F-AEF6-5F813C697BF4

Q39478909-152A3BCF-033D-4F10-AA05-EB44E42DE9C8

Q39478909-2C581FD0-D089-4C65-8A50-A2148670E083

Q39478909-3EA19AA1-EAD0-4AB5-B96A-C5C19E634F1D

Q39478909-497A64BA-C218-4CF1-A0E1-233F3ACBDBDC

Q39478909-4FB10498-8B3E-408E-B761-EE1458A5095F

Q39478909-52DC2ED2-AE17-4DE5-8254-F15736FAB7B5

Q39478909-56A28C6B-842F-4481-B791-D262D5DAFD18

Q39478909-59EF04F1-04C1-4225-BE1D-25A2294E2901

P304

Q39478909-67E5C1BA-4D6B-451D-9333-D2CAEFEAB9E4

P31

Q39478909-7F069151-7173-4508-8A06-F58102915A49

P356

Q39478909-69F405DD-9EBC-49EF-972D-1C1857AB3C50

P407

Q39478909-65ECC717-D9F4-48A4-8454-1E6D64E38FD9

P433

Q39478909-7034E38A-3CE1-4643-803A-FA4720B49B8D

P478

Q39478909-01CC029B-EEBA-4F1B-A405-BFC45C2BDAD1

P577

Q39478909-A57B46FB-254C-4086-974A-A521843FFEB0

P5875

Q39478909-91DB752C-EC13-48D4-BACC-3CF8F3EB66DF

P698

Q39478909-71164874-18A3-422B-B1E0-D932B9594758

P932

Q39478909-6E8102F0-8FBB-4494-8AC2-9AFB97C66A31

P356

AAC.45.11.3216-3219.2001

P1433

Antimicrobial Agents and Chemotherapy

P1476

Susceptibilities of oral bacteria and yeast to mammalian cathelicidins

@en

P2093

B F Tack

http://www.w3.org/2001/XMLSchema#string

J M Guthmiller

http://www.w3.org/2001/XMLSchema#string

K G Vargas

http://www.w3.org/2001/XMLSchema#string

L L Schomberg

http://www.w3.org/2001/XMLSchema#string

P B McCray

http://www.w3.org/2001/XMLSchema#string

P L Weistroffer

http://www.w3.org/2001/XMLSchema#string

R Srikantha

http://www.w3.org/2001/XMLSchema#string

P2860

The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders

Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.

The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6.

Bactericidal activity of mammalian cathelicidin-derived peptides.

Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.

Biochemical composition of human saliva in relation to other mucosal fluids.

In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins.

Molecular basis of Candida albicans adhesion.

P304

3216-3219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.45.11.3216-3219.2001

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11750756

http://www.w3.org/2001/XMLSchema#string

P698

11600383

http://www.w3.org/2001/XMLSchema#string

P932

90809

http://www.w3.org/2001/XMLSchema#string